To those that say DNA seq; although the cost to perform the actual sequence has dropped, there are still a ton of overhead costs in acquiring and managing any genomic data. Context - product platform guy at biobank.
Those two costs are what makeup the $1000/human genome stat, we don't factor in the human and consumables components
I'd like to see how those kind of costs stack up against the $0.6K-WGS. Yes, I understand the difference between marginal COGS and opex.